Effect of Food on the Relative Bioavailability of Prifetrastat in Healthy Participants

Phase 1, randomised, open-label trial of prifetrastat (2 arms), sponsored by Pfizer. Primary endpoints: Area under the concentration-time curve from time zero to extrapolated infinite time, Area under the concentration-time curve from time zero to time of last measurable concentration and 1 more. Planned start Jul 2026; status: not yet recruiting.